Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Multiple basal cell carcinomas in a patient with myotonic dystrophy type 1.

Saponaro AE, Marini MA, Rossi GC, Casas JG.

Int J Dermatol. 2006 Jan;45(1):87-8. No abstract available.

PMID:
16426388
2.

Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.

Zhao X, Ren W, Yang W, Wang Y, Kong H, Wang L, Yan L, Xu G, Fei J, Fu J, Zhang C, Wang Z.

Int J Cancer. 2006 Feb 1;118(3):643-8.

3.

The role of the Wnt signalling pathway in colorectal tumorigenesis.

Behrens J.

Biochem Soc Trans. 2005 Aug;33(Pt 4):672-5. Review.

PMID:
16042571
4.

DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.

Bartsch O, Schmidt S, Richter M, Morlot S, Seemanová E, Wiebe G, Rasi S.

Hum Genet. 2005 Sep;117(5):485-93. Epub 2005 Jul 14.

PMID:
16021471
5.

Lost in transcription: p21 repression, mechanisms, and consequences.

Gartel AL, Radhakrishnan SK.

Cancer Res. 2005 May 15;65(10):3980-5. Review.

6.

Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.

Ho TH, Bundman D, Armstrong DL, Cooper TA.

Hum Mol Genet. 2005 Jun 1;14(11):1539-47. Epub 2005 Apr 20.

PMID:
15843400
7.

Clinical and molecular aspects of the myotonic dystrophies: a review.

Machuca-Tzili L, Brook D, Hilton-Jones D.

Muscle Nerve. 2005 Jul;32(1):1-18. Review.

PMID:
15770660
8.

Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.

Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJ, Breuning MH, Hennekam RC, Peters DJ.

Am J Hum Genet. 2005 Apr;76(4):572-80. Epub 2005 Feb 10.

9.

Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.

Lazar AJ, Calonje E, Grayson W, Dei Tos AP, Mihm MC Jr, Redston M, McKee PH.

J Cutan Pathol. 2005 Feb;32(2):148-57.

PMID:
15606674
10.

[Anesthetic management for a patient of myotonic dystrophy with pheochromocytoma].

Ando T, Goto R, Ohnishi H, Ishida M, Obara H.

Masui. 2004 Nov;53(11):1290-2. Japanese.

PMID:
15587184
11.

Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.

Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y.

Mol Cell Biol. 2004 Dec;24(24):10689-702.

12.

Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence.

Kaaks R.

Novartis Found Symp. 2004;262:247-60; discussion 260-68. Review.

PMID:
15562834
13.

Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.

Saldanha G, Ghura V, Potter L, Fletcher A.

Br J Dermatol. 2004 Jul;151(1):157-64.

PMID:
15270885
14.

Muscleblind proteins regulate alternative splicing.

Ho TH, Charlet-B N, Poulos MG, Singh G, Swanson MS, Cooper TA.

EMBO J. 2004 Aug 4;23(15):3103-12. Epub 2004 Jul 15.

15.

p300/CBP and cancer.

Iyer NG, Ozdag H, Caldas C.

Oncogene. 2004 May 24;23(24):4225-31. Review.

PMID:
15156177
17.

Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease).

Montella L, Caraglia M, Addeo R, Costanzo R, Faiola V, Abbruzzese A, Del Prete S.

Ann Hematol. 2005 Mar;84(3):192-3. Epub 2004 Mar 23.

PMID:
15042318
18.

Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate.

Iakova P, Wang GL, Timchenko L, Michalak M, Pereira-Smith OM, Smith JR, Timchenko NA.

EMBO J. 2004 Jan 28;23(2):406-17. Epub 2004 Jan 15.

19.

Tissue and tumor mosaicism of the myotonin protein kinase gene trinucleotide repeat in a patient with multiple basal cell carcinomas associated with myotonic dystrophy.

Bañuls J, Botella R, Palau F, Ramón R, Díaz C, Payá A, Carnero L, Vergara G.

J Am Acad Dermatol. 2004 Feb;50(2 Suppl):S1-3.

PMID:
14726854
20.

A muscleblind knockout model for myotonic dystrophy.

Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS.

Science. 2003 Dec 12;302(5652):1978-80.

Supplemental Content

Support Center